Becton Dickinson & CoBDX
Price$178.07Intrinsic value$146.7418% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $146.74median of 5 methods · middle span $89-$170based on filings through 30 Jun 2026
Market Price $178.07Price as of 1 Oct 2026
Margin of Safety -17.6%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 8.5%/yr (balance of the path).7.8% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 68.4%Yr 78.2%Yr 88.1%Yr 97.9%Yr 107.8%
8.5% → 7.8%
Years 11–20: glide to long-run rate
Per-year rates
Yr 117.3%Yr 126.8%Yr 136.4%Yr 145.9%Yr 155.4%Yr 164.9%Yr 174.4%Yr 184.0%Yr 193.5%Yr 203.0%
7.8% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)16.5%
Discount rate (cost of equity) 7.0%
Volatility vs market (adjusted beta)0.47

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetBecton Dickinson & CoBDXHealth Care
Valuation
P/E53.8×
P/S2.2×
P/B2.1×
EV / Revenue2.9×
EV / EBITDA—
Profitability
Gross margin—
Operating margin10.7%
Net margin4.2%
FCF margin—
Returns
ROE3.9%
ROA1.9%
ROIC2.3%
Growth
Revenue growth (YoY)11.4%
5-yr fwd EPS growth7.8%
Financial strength
Debt / Equity0.69×
Current ratio0.87×
Altman Z-Score2.2
Interest coverage—
Dividend yield1.1%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.